Description
The intravenous induction agent, etomidate, was introduced into clinical practice in 1972. Although not widely used for routine anaesthesia, many believe its properties enable it to occupy a specific niche in anaesthetic practice. Its use by non anaesthetists in many countries seems to be expanding and this, and its unique properties, have resulted in renewed interest (and controversy) regarding etomidate in recent years. This article reviews the pharmacology and current role in clinical practice
of etomidate.
